Cystic fibrosis patients lobby Vertex to drop drug prices

Healthcare professionals and patient groups have written to Vertex’s CEO Jeffrey Leiden in a bid to resolve a funding row over cystic fibrosis drugs, as UK MPs prepare to hold a public hearing investigating their price.